Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications
Pharmacodynamic analysis of TYK2 inhibition by deucravacitinib: results from the phase 2 PAISLEY SLE trial in patients with active systemic lupus erythematosus.
Journal: Annals of the rheumatic diseases
Published: December 04, 2025
Whole blood transcriptome profiling in patients treated with deucravacitinib and novel mechanistic insights into TYK2 inhibition in lupus: results from a post hoc analysis of the PAISLEY SLE phase 2 trial.
Journal: Annals of the rheumatic diseases
Published: September 23, 2025
Type I interferons in health and disease: molecular aspects and clinical implications.
Journal: Physiological reviews
Published: July 10, 2025
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024.
Journal: Annals of the rheumatic diseases
Published: October 11, 2024
Highlights from the 2024 Rheumatoid Arthritis Research Summit.
Journal: Seminars in arthritis and rheumatism
Published: October 03, 2024
Systemic lupus erythematosus genetics: insights into pathogenesis and implications for therapy.
Journal: Nature reviews. Rheumatology
Published: July 30, 2024
Mechanosensing regulates pDC activation in the skin through NRF2 activation.
Journal: The Journal of experimental medicine
Published: May 15, 2024
Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity.
Journal: Immunological reviews
Published: March 30, 2024
Charles L Christian: Model Physician Scientist and Mentor.
Journal: Rheumatic diseases clinics of North America
Published: November 16, 2023
Standing on Shoulders: Interferon Research From Viral Interference to Lupus Pathogenesis and Treatment.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: November 14, 2023
Investigation of Possible Link between Interferon-α and Lyme Disease.
Journal: Emerging infectious diseases
Published: October 25, 2023
Last Updated: 09/26/2026